Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Protocol for high throughput 3D drug screening of patient derived melanoma and renal cell carcinoma

SLAS DISCOVERY(2024)10.1016/j.slasd.2024.01.002Source: DataRank Database

Protocol for high throughput 3D drug screening of patient derived melanoma and renal cell carcinoma is a research paper published in SLAS DISCOVERY (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.86)OA: goldTopics (49)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Virneliz Fernández Vega,Justin Shumate ORCID,A. Mihaljević Peleš,Jordan Zeiger,Louis Scampavia ORCID

Live enrichment

PubMed:38218316 PMC:PMC11542555 OpenAlex:https://openalex.org/W4390736458

NIH HHS

Grant: S10 OD030330

NCI NIH HHS

Grant: R33 CA206949

NIH HHS

Grant: S10 OD025279

NIH HHS

Grant: S10 OD026857

FWCI

0.86

Citation Percentile

0.7%

Citation Trend

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://slas-discovery.org/article/S2472555224000029/pdf

publisherhttp://slas-discovery.org/article/S2472555224000029/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2472555224000029?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2472555224000029?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.slasd.2024.01.002

Fields of Study

3D Printing in Biomedical ResearchCancer Cells and MetastasisCell Image Analysis TechniquesHumansCarcinoma, Renal CellHigh-Throughput Screening AssaysMelanomaDrug Screening Assays, AntitumorAntineoplastic AgentsKidney NeoplasmsCell Culture TechniquesCell Line, TumorCell Culture Techniques, Three DimensionalDrug Evaluation, Preclinical

MeSH Terms

Cell Culture Techniques, Three DimensionalAntineoplastic AgentsCarcinoma, Renal CellDrug Evaluation, PreclinicalDrug Screening Assays, AntitumorHumansKidney NeoplasmsMelanomaCell Culture TechniquesCell Line, TumorHigh-Throughput Screening Assays

Keywords

3D cell cultureMedicineRenal cell carcinomaDrugCancer researchCancerMelanomaCancer cell linesCell cultureCancer cellComputational biologyOncologyBioinformaticsInternal medicinePharmacologyBiologyRenal carcinomaHTSRccPhenotypicOrganoidScaffold FreePatient Derived Organoids3D Cell Models

Sustainable Development Goals

SDG 0: Good health and well-being

Protocol for high throughput 3D drug screening of patient derived melanoma and renal cell carcinoma

FAIR Checklist

Authors (7)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)